Answers are grounded in this paper and cite their sources.
// Qinhong Xu 1 ,* , Pei Li 1 ,2,* , Xin Chen 1 , Liang Zong 1 , Zhengdong Jiang 1 , Ligang Nan 1 , Jianjun Lei 1 , Wanxing Duan 1 , Dong Zhang 1 , Xuqi Li 3 , Huanchen Sha 1 , Zheng Wu 1 Qingyong Ma 1 and Zheng Wang 1 1 Department of Hepatobiliary Surgery, First Affiliated Hospital Medical College of Xi’an Jiaotong University, Xi’an, Shaanxi, China 2 Department of Thoracic Surgery, Tangdu Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China 3 Department of General Surgery, First Affiliated Hospital Medical College of Xi’an Jiaotong University, Xi’an, Shaanxi, China * These authors have contributed equally to this work Correspondence to: Zheng Wang, email: // Keywords : miR-221/222, pancreatic cancer, matrix metalloproteinases Received : December 20, 2014 Accepted : March 03, 2015 Published : March 29, 2015 Abstract MicroRNAs are involved in the initiation and progression of pancreatic cancer. In this study, we showed that miR-221/222 is overexpressed in pancreatic cancer. MiR-221/222 overexpression significantly promoted pancreatic cancer cell proliferation and invasion while inhibiting apoptosis. The expression of the matrix metalloproteinases (MMPs) MMP-2 and MMP-9 was increased in miR-221/222 mimic-transfected pancreatic cancer cells. Validation experiments identified TIMP-2 as a direct target of miR-221/222. These data indicate that overexpressed miR-221/222 may play an oncogenic role in pancreatic cancer by inducing the expression of MMP-2 and MMP-9, thus leading to cancer cell invasion.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: